197
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Peptidomics in drug research

, , , &
Pages 425-440 | Published online: 26 Mar 2008

Bibliography

  • Liu F, Baggerman G, D'Hertog W, et al. In silico identification of new secretory peptide genes in Drosophila melanogaster. Mol Cell Proteomics 2006;5:510-22
  • Liu F, Baggerman G, Schoofs L, et al. Uncovering conserved patterns in bioactive peptides in Metazoa. Peptides 2006;27:3137-53
  • Clynen E, Baggerman G, Veelaert D, et al. Peptidomics of the pars intercerebralis-corpus cardiacum complex of the migratory locust, Locusta migratoria. Eur J Biochem 2001;268:1929-39
  • Verhaert P, Uttenweiler-Joseph S, de Vries M, et al. Matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry: an elegant tool for peptidomics. Proteomics 2001;1:118-31
  • Clynen E, De Loof A, Schoofs L. The use of peptidomics in endocrine research. Minireview. Gen Comp Endocrinol 2003;132:1-9
  • Baggerman G, Verleyen P, Clynen E, et al. Peptidomics. J Chromatogr B Analyt Technol Biomed Life Sci 2004;803:3-16
  • Schulz-Knappe P, Zucht HD, Heine C, et al. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb Chem High Throughput Screen 2001;4:207-17
  • Ivanov VT, Yatskin ON. Peptidomics: a logical sequel to proteomics. Expert Rev Proteomics 2005;2:463-73
  • Baggerman G, Cerstiaens A, De Loof A, et al. Peptidomics of the larval Drosophila melanogaster central nervous system. J Biol Chem 2002;277:40368-74
  • Boonen K, Baggerman G, D'Hertog W, et al. Neuropeptides of the islets of Langerhans: a peptidomics study. Gen Comp Endocrinol 2007;152:231-41
  • Svensson M, Skold K, Nilsson A, et al. Neuropeptidomics: expanding proteomics downwards. Biochem Soc Trans 2007;35:588-93
  • Tatemoto K, Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 1980;285:417-8
  • Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10 000 Daltons. Anal Chem 1988;60:1299-301
  • Yamashita M, Fenn JB. Electrospray ion source. Another variation on the free-jet theme. J Phys Chem 1984;88:4451-9
  • Schulz-Knappe P, Schrader M, Zucht HD. The peptidomics concept. Comb Chem High Throughput Screen 2005;8:697-704
  • Jürgens M, Schrader M. Peptidomic approaches in proteomic research. Curr Opin Mol Ther 2002;4:236-41
  • Husson SJ, Baggerman G, Clynen E, et al. Peptidomics: the search for endogenous neuropeptides by mass spectrometry is coming of age. In: Farley EP, editor, Progress in neuropeptide research. Nova Science Publishers, Inc., New York; 2007. p. 95-123
  • Available from: www.ncbi.nlm.nih.gov/pubmed/
  • Baggerman G, Boonen K, Verleyen P, et al. Peptidomic analysis of the larval Drosophila melanogaster central nervous system by two-dimensional capillary liquid chromatography quadrupole time-of-flight mass spectrometry. J Mass Spectrom 2005;40:250-60
  • Husson SJ, Clynen E, Baggerman G, et al. Discovering neuropeptides in Caenorhabditis elegans by two dimensional liquid chromatography and mass spectrometry. Biochem Biophys Res Commun 2005;335:76-86
  • Fricker LD, Lim J, Pan H, et al. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev 2006;25:327-44
  • Johansson C, Samskog J, Sundstrom L, et al. Differential expression analysis of Escherichia coli proteins using a novel software for relative quantitation of LC-MS/MS data. Proteomics 2006;6:4475-85
  • Wu CC, MacCoss MJ, Howell KE, et al. Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem 2004;76:4951-9
  • Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999;17:994-9
  • Che FY, Fricker LD. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J Mass Spectrom 2005;40:238-49
  • Available from: www.swepep.org
  • Fälth M, Skold K, Norrman M, et al. SwePep, a database designed for endogenous peptides and mass spectrometry. Mol Cell Proteomics 2006;5:998-1005
  • Fälth M, Skold K, Svensson M, et al. Neuropeptidomics strategies for specific and sensitive identification of endogenous peptides. Mol Cell Proteomics 2007;6:1188-97
  • Available from: http://neuroproteomics.scs.uiuc.edu/neuropred.html
  • Southey BR, Amare A, Zimmerman TA, et al. NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucleic Acids Res 2006;34:W267-72
  • Available from: http://peptides.statik.be/
  • Liu F, Baggerman G, Schoofs L, et al. Construction of a database of signalling peptides in Metazoa. J Proteome Res 2008; submitted
  • KieberEmmons T, Murali R, Greene MI. Therapeutic peptides and peptidomimetics. Curr Opin Biotech 1997;8:435-41
  • Shechter Y, Mironchik M, Saul A, et al. New technologies to prolong life-time of peptide and protein drugs in vivo. Int J Pept Res Ther 2007;13:105-17
  • Schulz-Knappe P, Schrader M. Peptidomics in biomarker and drug discovery. Curr Drug Discov 2003:21-4
  • Available from: http://merops.sanger.ac.uk
  • Rawlings ND, Morton FR, Yin Kok C, et al. MEROPS: the peptidase database. Nucleic Acids Res 2008;36:D320-5
  • Jost M, Budde P, Tammen H, et al. Peptidomics based protease inhibitor profiling. In: Schulz-Knappe P, editor, Peptidomics in drug development. Editio Cantor, Aulendorf; 2007. p. 65-73
  • Saberi R, Sehgal A. BioMarket trends: process improvements bolster peptide drug market. Genet Eng Biotechnol News 2007:27
  • Maggio ET. A renaissance in peptide therapeutics is underway. Drug Deliv Rep Spring/Summer 2006:23-6
  • Crameri R. The potential of proteomics and peptidomics for allergy and asthma research. Allergy 2005;60:1227-37
  • Budde P, Schulte I, Appel A, et al. Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. Comb Chem High Throughput Screen 2005;8:775-81
  • Svensson M, Skold K, Nilsson A, et al. Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Anal Chem 2007;79:15-21
  • Skold K, Svensson M, Kaplan A, et al. A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics 2002;2:447-54
  • Che FY, Lim J, Pan H, et al. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics 2005;4:1391-405
  • Fricker LD. Neuropeptidomics to study peptide processing in animal models of obesity. Endocrinology 2007;148:4185-90
  • Bergquist J, Ekman R. Future aspects of psychoneuroimmunology – lymphocyte peptides reflecting psychiatric disorders studied by mass spectrometry. Arch Physiol Biochem 2001;109:369-71
  • Selle H, Lamerz J, Buerger K, et al. Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb Chem High Throughput Screen 2005;8:801-6
  • Skold K, Svensson M, Nilsson A, et al. Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J Proteome Res 2006;5:262-9
  • Kamphorst JJ, Heijden RV, Degroot J, et al. Profiling of endogenous peptides in human synovial fluid by nanoLC-MS: method validation and peptide identification. J Proteome Res 2007;6:4388-96
  • Hardt M, Witkowska HE, Webb S, et al. Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents. Anal Chem 2005;77:4947-54
  • Schrader M, Schulz-Knappe P. Peptidomics technologies for human body fluids. Trends Biotechnol 2001;19:S55-60
  • Heine G, Raida M, Forssmann WG. Mapping of peptides and protein fragments in human urine using liquid chromatography mass spectrometry. J Chromatogr A 1997;776:117-24
  • Jürgens M, Appel A, Heine G, et al. Towards characterization of the human urinary peptidome. Comb Chem High Throughput Screen 2005;8:757-65
  • Norden AG, Rodriguez-Cutillas P, Unwin RJ. Clinical urinary peptidomics: learning to walk before we can run. Clin Chem 2007;53:375-6
  • Sato K, Sasaki K, Akiyama Y, et al. Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines. Cancer Lett 2001;170:153-9
  • Sato K, Sasaki K, Tsao MS, et al. Peptide differential display of serum-free conditioned medium from cancer cell lines. Cancer Lett 2002;176:199-203
  • Jost MM, Budde P, Tammen H, et al. The concept of functional peptidomics for the discovery of bioactive peptides in cell culture models. Comb Chem High Throughput Screen 2005;8:767-73
  • Tammen H, Kreipe H, Hess R, et al. Expression profiling of breast cancer cells by differential peptide display. Breast Cancer Res Treat 2003;79:83-93
  • Sasaki K, Sato K, Akiyama Y, et al. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 2002;62:4894-8
  • Tammen H, Schulte I, Hess R, et al. Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. Comb Chem High Throughput Screen 2005;8:725-33
  • Tammen H, Schulte I, Hess R, et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005;5:3414-22
  • Richter R, Schulz-Knappe P, Schrader M, et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B 1999;726:25-35
  • Xiang Y, Matsui T, Matsuo K, et al. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells. Arthritis Rheum 2007;56:2018-30
  • Lamerz J, Selle H, Scapozza L, et al. Correlation-associated peptide networks of human cerebrospinal fluid. Proteomics 2005;5:2789-98
  • Menez A, Stocklin R, Mebs D. ‘Venomics'or: the venomous systems genome project. Toxicon 2006;47:255-9
  • Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nat Rev Drug Discov 2003;2:790-802
  • Opie LH, Kowolik H. The discovery of captopril: from large animals to small molecules. Cardiovasc Res 1995;30:18-25
  • Gowd KH, Sabareesh V, Sudarslal S, et al. Novel peptides of therapeutic promise from Indian Conidae. Ann NY Acad Sci 2005;1056:462-73
  • Mortari MR, Cunha AO, Ferreira LB, et al. Neurotoxins from invertebrates as anticonvulsants: from basic research to therapeutic application. Pharmacol Ther 2007;114:171-83
  • Available from: www.conco.eu
  • van't Hof W, Veerman EC, Helmerhorst EJ, et al. Antimicrobial peptides: properties and applicability. Biol Chem 2001;382:597-619
  • Vanhoye D, Bruston F, Nicolas P, et al. Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain. Eur J Biochem 2003;270:2068-81
  • Meyer JE, Harder J. Antimicrobial peptides in oral cancer. Curr Pharm Des 2007;13:3119-30
  • Vassilatis DK, Hohmann JG, Zeng H, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003;100:4903-8
  • Civelli O, Saito Y, Wang Z, et al. Orphan GPCRs and their ligands. Pharmacol Ther 2006;110:525-32
  • Schrader M, Selle H. The process chain for peptidomic biomarker discovery. Dis Markers 2006;22:27-37
  • Petricoin EF, Belluco C, Araujo RP, et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer 2006;6:961-7
  • Honeybee genome sequencing consortium. Insights into social insects from the genome of the honeybee Apis mellifera. Nature 2006;443:931-49
  • Jürgens M, Appel A, Heine G, et al. Towards characterization of the human urinary peptidome. Comb Chem High Throughput Screen 2005;8:757-65
  • Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med 2003;139:194-204
  • Abbenante G, Kovacs DM, Leung DL, et al. Inhibitors of beta-amyloid formation based on the beta-secretase cleavage site. Biochem Biophys Res Commun 2000;268:133-5
  • Chesnut CH III, Azria M, Silverman S, et al. Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int 2007; In Press
  • Reissmann T, Schally AV, Bouchard P, et al. The LHRH antagonist cetrorelix: a review. Hum Reprod Update 2000;6:322-31
  • Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 2007;82:731-5
  • Green BD, Flatt PR. Incretin hormone mimetics and analogues in diabetes therapeutics. Best Pract Res Clin Endocrinol Metab 2007;21:497-516
  • Crotty S, Reynolds SL. The new insulins. Pediatr Emerg Care 2007;23:903-5
  • Wilson AC, Meethal SV, Bowen RL, et al. Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs 2007;16:1851-63
  • Tsatsaris V, Carbonne B, Cabrol D. Atosiban for preterm labour. Drugs 2004;64:375-82
  • Singh-Franco D, Robles G, Gazze D. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus. Clin Ther 2007;29:535-62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.